BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22855342)

  • 1. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.
    Newey PJ; Nesbit MA; Rimmer AJ; Attar M; Head RT; Christie PT; Gorvin CM; Stechman M; Gregory L; Mihai R; Sadler G; McVean G; Buck D; Thakker RV
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1995-2005. PubMed ID: 22855342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of somatic mutations in parathyroid tumors using whole-exome sequencing.
    Cromer MK; Starker LF; Choi M; Udelsman R; Nelson-Williams C; Lifton RP; Carling T
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1774-81. PubMed ID: 22740705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Exome Sequencing Identifies Novel Recurrent Somatic Mutations in Sporadic Parathyroid Adenomas.
    Wei Z; Sun B; Wang ZP; He JW; Fu WZ; Fan YB; Zhang ZL
    Endocrinology; 2018 Aug; 159(8):3061-3068. PubMed ID: 29982334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients.
    Romero Arenas MA; Fowler RG; San Lucas FA; Shen J; Rich TA; Grubbs EG; Lee JE; Scheet P; Perrier ND; Zhao H
    Surgery; 2014 Dec; 156(6):1351-7; discussion 1357-8. PubMed ID: 25456907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
    Miedlich S; Krohn K; Lamesch P; Müller A; Paschke R
    Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of primary hyperparathyroidism.
    Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas.
    Costa-Guda J; Soong CP; Parekh VI; Agarwal SK; Arnold A
    Horm Cancer; 2013 Oct; 4(5):301-7. PubMed ID: 23715670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
    Karges W; Jostarndt K; Maier S; Flemming A; Weitz M; Wissmann A; Feldmann B; Dralle H; Wagner P; Boehm BO
    J Endocrinol; 2000 Jul; 166(1):1-9. PubMed ID: 10856877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
    Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.
    Costa-Guda J; Marinoni I; Molatore S; Pellegata NS; Arnold A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E701-6. PubMed ID: 21289244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
    Kim BY; Park MH; Woo HM; Jo HY; Kim JH; Choi HJ; Koo SK
    BMC Med Genet; 2017 Oct; 18(1):106. PubMed ID: 28969599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.
    Carling T; Correa P; Hessman O; Hedberg J; Skogseid B; Lindberg D; Rastad J; Westin G; Akerström G
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2960-3. PubMed ID: 9709976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
    Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
    Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.
    Bräutigam K; Nesti C; Riss P; Scheuba C; Niederle B; Grob T; Di Domenico A; Neuenschwander M; Mazal P; Köhn N; Trepp R; Perren A; Kaderli RM
    Virchows Arch; 2024 May; 484(5):789-798. PubMed ID: 38244045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-exome sequencing studies of nonfunctioning pituitary adenomas.
    Newey PJ; Nesbit MA; Rimmer AJ; Head RA; Gorvin CM; Attar M; Gregory L; Wass JA; Buck D; Karavitaki N; Grossman AB; McVean G; Ansorge O; Thakker RV
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E796-800. PubMed ID: 23450047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors.
    Uchino S; Noguchi S; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Ohshima A; Futata T; Mizukoshi T; Koike E; Takatsu K; Terao K; Wakiya S; Nagatomo M; Adachi M
    Cancer Res; 2000 Oct; 60(19):5553-7. PubMed ID: 11034102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic insights into sporadic primary hyperparathyroidism.
    Brewer K; Costa-Guda J; Arnold A
    Endocr Relat Cancer; 2019 Feb; 26(2):R53-R72. PubMed ID: 30475215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM.
    Arnold A
    Trans Am Clin Climatol Assoc; 2016; 127():235-244. PubMed ID: 28066056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
    Scarpelli D; D'Aloiso L; Arturi F; Scillitani A; Presta I; Bisceglia M; Cristofaro C; Russo D; Filetti S
    J Endocrinol Invest; 2004 Dec; 27(11):1015-21. PubMed ID: 15754732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.
    Cetani F; Pardi E; Vignali E; Borsari S; Picone A; Cianferotti L; Ambrogini E; Miccoli P; Pinchera A; Marcocci C
    J Endocrinol Invest; 2002 Jun; 25(6):508-12. PubMed ID: 12109621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.